Zerbe Horst G 4

4 · IntelGenx Technologies Corp. · Filed Jan 31, 2023

Form 4

Period: 2023-01-29

DirectorCEO, President10% Owner

Transactions

Award
Options (right to buy) p.v.0.00001
2023-01-29+37,500→ 692,408 total
Exercise: $0.24From: 2026-01-29Exp: 2033-01-28→ Common Stock (37,500 underlying)
Award
Options (right to buy) p.v.0.00001
2023-01-29+37,500→ 617,408 total
Exercise: $0.24From: 2024-01-29Exp: 2033-01-28→ Common Stock (37,500 underlying)
Award
Options (right to buy) p.v.0.00001
2023-01-29+37,500→ 654,908 total
Exercise: $0.24From: 2025-01-29Exp: 2033-01-28→ Common Stock (37,500 underlying)
Award
Restricted Share Units (p.v.0.00001 )
2023-01-29+125,000→ 155,769 total
Exercise: $0.00Exp: 2026-01-28→ Common Stock (125,000 underlying)
Award
Options (right to buy) p.v.0.00001
2023-01-29+37,500→ 729,908 total
Exercise: $0.24From: 2027-01-29Exp: 2033-01-28→ Common Stock (37,500 underlying)

Footnotes (2)

[F1]The award vests as follows: 25% on each of January 29, 2024; 2025; 2026 and 2027, each vesting subject to acceleration upon Issuer's common stock achieving a specified price per share.
[F2]Each performance right represents a contingent right to receive one share of Issuer's common stock. The performance rights vest upon Issuer's common stock achieving a specified price per share.

Documents

1 file